Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Dirix, L. Y
233  Ergebnisse:
Personensuche X
?
1

52P Clinical characterization of HER2 low in patients with ..:

Van Baelen, K. ; Nguyen, H.L. ; Richard, F....
ESMO Open.  8 (2023)  1 - p. 101276 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Impact of age on breast cancer mortality and competing caus..:

Derks, M.G.M. ; Bastiaannet, E. ; van de Water, W....
European Journal of Cancer.  99 (2018)  - p. 1-8 , 2018
Link: https://doi.org/10.1016/..
 
?
3

1883 Prevalence and prognostic impact of HER2-positive circ..:

Beije, N. ; Onstenk, W. ; Kraan, J....
European Journal of Cancer.  51 (2015)  - p. S294 , 2015
Link: https://doi.org/10.1016/..
 
?
4

Mechanisms of tumour vascularization in cutaneous malignant..:

Pastushenko, I. ; Vermeulen, P.B. ; Van den Eynden, G.G....
British Journal of Dermatology.  171 (2014)  2 - p. 220-233 , 2014
Link: https://doi.org/10.1111/..
 
?
5

Blood microvessel density, lymphatic microvessel density an..:

Pastushenko, I. ; Vermeulen, P.B. ; Carapeto, F.J....
British Journal of Dermatology.  170 (2014)  1 - p. 66-77 , 2014
Link: https://doi.org/10.1111/..
 
?
6

440. The Histological Growth Pattern of Colorectal Liver Me..:

Majeed, A. ; Van den Eynden, G. ; Bird, N.C....
European Journal of Surgical Oncology.  38 (2012)  9 - p. 860 , 2012
Link: https://doi.org/10.1016/..
 
?
7

421 ER Allred Score Predicts Outcome of Adjuvant Endocrine ..:

van de Water, W. ; Fontein, D.B.Y. ; Bartlett, J.M.S....
European Journal of Cancer.  48 (2012)  - p. S169 , 2012
Link: https://doi.org/10.1016/..
 
?
8

198 Specific Adverse Events Predict Survival Benefit in Ear..:

Fontein, D. ; Houtsma, D. ; Hille, E.T.M....
European Journal of Cancer.  48 (2012)  - p. S101 , 2012
Link: https://doi.org/10.1016/..
 
?
9

Effect of trabectedin on the QT interval in patients with a..:

Thertulien, R. ; Manikhas, G. M. ; Dirix, L. Y....
Cancer Chemotherapy and Pharmacology.  69 (2011)  2 - p. 341-350 , 2011
Link: https://doi.org/10.1007/..
 
?
10

Bevacizumab in the treatment of patients with advanced brea..:

Dirix, L.Y. ; Van Dam, P.A. ; Prove, A.M..
Therapeutic Advances in Medical Oncology.  2 (2010)  5 - p. 331-342 , 2010
Link: https://doi.org/10.1177/..
 
?
11

5136 Tamoxifen and exemestane adjuvant multinational (TEAM)..:

Seynaeve, C. ; van de Velde, C.J.H. ; Maartense, E....
European Journal of Cancer Supplements.  7 (2009)  2 - p. 300 , 2009
Link: https://doi.org/10.1016/..
 
?
12

5007 ORAL Correlation of the AKT/mTOR/p70S6K1 pathway and p..:

Trinh, X.B. ; Tjalma, W.A.A. ; Dirix, L.Y....
European Journal of Cancer Supplements.  5 (2007)  4 - p. 313 , 2007
Link: https://doi.org/10.1016/..
 
?
13

A fibrotic focus is a prognostic factor and a surrogate mar..:

Van den Eynden, G G ; Colpaert, C G ; Couvelard, A...
Histopathology.  51 (2007)  4 - p. 440-451 , 2007
Link: https://doi.org/10.1111/..
 
?
14

8015 ORAL Stepwise implementation of an evidence-based spec..:

Verheyden, G. ; van der Mussele, H. ; Prove, A.M....
European Journal of Cancer Supplements.  5 (2007)  4 - p. 416 , 2007
Link: https://doi.org/10.1016/..
 
?
15

313 POSTER Comparison of molecular determinants of angiogen..:

van den Eynden, G.G. ; van der Auwera, I. ; van Laere, S.J....
European Journal of Cancer Supplements.  5 (2007)  4 - p. 60-61 , 2007
Link: https://doi.org/10.1016/..
 
1-15